Fuji Pharma Co., Ltd. (FUP) Stock Statistics & Valuation Metrics
Total Valuation
Fuji Pharma Co., Ltd. has a market cap or net worth of EUR 277.06M. The enterprise value is EUR 71.00B.
- Market Cap
- EUR 277.06M
- Enterprise Value
- EUR 71.00B
Share Statistics
Fuji Pharma Co., Ltd. has 26,541,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 26,541,100
- Owned by Insiders
- ―
- Owned by Institutions
- 6.61%
Financial Efficiency
Fuji Pharma Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.65%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 4.65%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 29.36M
- Profits Per Employee
- 1.70M
- Employee Count
- 1,760
- Asset Turnover
- 0.55
- Inventory Turnover
- 1.53
Valuation Ratios
The current PE Ratio of Fuji Pharma Co., Ltd. is 15.89. Fuji Pharma Co., Ltd.’s PEG ratio is -2.88.
- PE Ratio
- 15.89
- PS Ratio
- 0.82
- PB Ratio
- 0.95
- Price to FCF
- 12.93
- Price to Operating Cash Flow
- 8.51
- PEG Ratio
- -2.88
Income Statement
In the last 12 months, Fuji Pharma Co., Ltd. had revenue of 51.68B and earned 3.00B in profits. Earnings per share was 122.93.
- Revenue
- 51.68B
- Gross Profit
- 19.29B
- Operating Income
- 4.99B
- Pretax Income
- 4.00B
- Net Income
- 3.00B
- EBITDA
- 8.96B
- Earnings Per Share (EPS)
- 122.93
Cash Flow
In the last 12 months, operating cash flow was 5.80B and capital expenditures -1.98B, giving a free cash flow of 3.82B billion.
- Operating Cash Flow
- 5.80B
- Free Cash Flow
- 3.82B
- Free Cash Flow per Share
- 146.25
Dividends & Yields
Fuji Pharma Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 2.18%
- Dividend Per Share
- ―
- Dividend Yield
- 2.18%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.99%
- Earnings Yield
- 6.25%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- 13.97%
- 50-Day Moving Average
- 9.88
- 200-Day Moving Average
- 10.99
- Relative Strength Index (RSI)
- 61.51
- Average Volume (3m)
- ―
Important Dates
Fuji Pharma Co., Ltd. upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Fuji Pharma Co., Ltd. as a current ratio of 1.55, with Debt / Equity ratio of 65.96%
- Current Ratio
- 1.55
- Quick Ratio
- 0.86
- Debt to Market Cap
- 0.70
- Net Debt to EBITDA
- 2.65
- Interest Coverage Ratio
- 15.12
Taxes
In the past 12 months, Fuji Pharma Co., Ltd. has paid 1.00B in taxes.
- Income Tax
- 1.00B
- Effective Tax Rate
- 0.25
Enterprise Valuation
Fuji Pharma Co., Ltd. EV to EBITDA ratio is 5.99, with an EV/FCF ratio of 17.48.
- EV to Sales
- 1.11
- EV to EBITDA
- 5.99
- EV to Free Cash Flow
- 17.48
- EV to Operating Cash Flow
- 11.51
Balance Sheet
Fuji Pharma Co., Ltd. has EUR 9.95B in cash and marketable securities with EUR 28.89B in debt, giving a net cash position of -EUR 18.94B billion.
- Cash & Marketable Securities
- EUR 9.95B
- Total Debt
- EUR 28.89B
- Net Cash
- -EUR 18.94B
- Net Cash Per Share
- -EUR 713.69
- Tangible Book Value Per Share
- EUR 1,467.74
Margins
Gross margin is 39.39%, with operating margin of 11.67%, and net profit margin of 4.97%.
- Gross Margin
- 39.39%
- Operating Margin
- 11.67%
- Pretax Margin
- 5.68%
- Net Profit Margin
- 4.97%
- EBITDA Margin
- 18.53%
- EBIT Margin
- 11.67%
Analyst Forecast
The average price target for Fuji Pharma Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.84%
- EPS Growth Forecast
- -13.90%
